We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Synexus Continues to Expand Clinical Trials Activities in Poland

Synexus Continues to Expand Clinical Trials Activities in Poland

Synexus Continues to Expand Clinical Trials Activities in Poland

Synexus Continues to Expand Clinical Trials Activities in Poland

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Synexus Continues to Expand Clinical Trials Activities in Poland"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Synexus, a multi-national company engaged in the recruitment and running of clinical trials is expanding its operations in Gdynia, Poland when it moves to new premises later this year. It has also recently increased the capacity of its original centre in Wroclaw by several hundred square metres.

The new research centre in Gdynia will have the capacity for four full-time investigators, with an increase from one hundred to three hundred square metres of space and will include a wide range of diagnostic instruments to cover Synexus’ expanding therapy area coverage.

Dr Radoslaw Janiak, Synexus Country Manager for Poland says he is delighted with Synexus’ progress in Poland: “Being part of Synexus’ worldwide operations means that we are increasingly involved in large global clinical trials, we are able to recruit the right numbers of patients within the right time frame and that’s exactly what sponsors are looking for.”

Dr Janiak continued, “We are seeing considerable interest from a number of leading pharmas and CROs who are keen on the developments we have underway to increase our capacity here. In addition, the conference we organized in December has helped to raise awareness of the importance of clinical trials in Poland and has caught the attention of a number of senior medical professionals keen to develop their role and that of their organization, in the vital area of clinical research and the importance of the sector to improving healthcare in Poland.”

Synexus has been operating in Poland since 2006 from its site in Wroclaw and expanded its operations there in August 2009 when it acquired three new dedicated research centres in Warsaw, Gdynia and Katowice, following its takeover of CLCC.

Chief Executive Michael Fort believes that there is substantial scope to develop his company’s business in Poland: “We are continuing to see increased levels of interest for clinical trials throughout the CEE, not least in Poland where our sites are very well located and staffed by highly qualified and experienced professionals. The pharma companies and CROs we are talking to continue to express their enthusiasm for increased capacity across the CEE and we are keen to help meet their demands.”